PTAB challenges

Proceedings overview

As of May 29, 2026, there are no AIA trial proceedings (Inter Partes Review, Post-Grant Review, or Covered Business Method) on file for US Patent 7,020,281 with the USPTO Open Data Portal. A comprehensive web search also did not reveal any PTAB proceedings related to this patent. Therefore, all claims of US Patent 7,020,281 remain untested by the PTAB.

Strategic summary

Currently, all claims (1-9) of US Patent 7,020,281 remain untested by the Patent Trial and Appeal Board. The absence of PTAB activity suggests that either the patent has not been challenged through these mechanisms, or any challenges filed were not instituted or have been sealed. Given the patent expired on February 4, 2021, any new AIA trial proceedings are unlikely, as IPRs and PGRs typically target active patents to resolve validity disputes.

For a defendant currently facing assertion of this patent, the estoppel landscape under 35 U.S.C. § 315(e)(2) is not applicable, as no PTAB trials have occurred. This means that all prior art grounds remain available for challenge in district court litigation. The lack of PTAB activity indicates that the claims have not been "hardened" by surviving IPRs, nor have they been invalidated through such proceedings. The current assignee, Malikie Innovations Limited, appears to be asserting this expired patent in district court litigation.

Recommended next steps

Given the absence of PTAB activity for US Patent 7,020,281, a defendant facing assertion of this patent should consider the following:

• Validity Challenge in District Court: Since no PTAB proceedings have tested the patent's claims, all prior art grounds (under 35 U.S.C. §§ 102 and 103) remain available for a defendant to assert in a district court invalidity defense. The prior art discussed in the "Prior Art" and "Obviousness" sections (e.g., Kocher's 1996 paper, US 5,991,415, US 6,175,850, and US 6,366,673) provides strong potential grounds for invalidity arguments against claims 1 and 6.
• Patent Expiration: Emphasize that the patent expired on February 4, 2021. This limits potential damages to activity occurring before this date and precludes injunctions for future activity.
• Stay of Litigation (if applicable): While direct PTAB challenges are unlikely for an expired patent, if parallel litigation is ongoing in district court, the defendant could explore motions to stay proceedings if other avenues of validity challenge (e.g., inter partes reexamination, if still permissible) were contemplated, though this is less common for expired patents.
• Analysis of Surviving Claims: All claims (1-9) are technically "surviving" as they have not been challenged at the PTAB. A thorough independent prior art search and analysis of each claim against the identified prior art (and potentially new art) is critical to developing a robust invalidity defense in district court.## Proceedings overview

As of May 29, 2026, there are no AIA trial proceedings (Inter Partes Review, Post-Grant Review, or Covered Business Method) on file for US Patent 7,020,281 with the USPTO Open Data Portal. A comprehensive web search also did not reveal any PTAB proceedings related to this patent. Therefore, all claims of US Patent 7,020,281 remain untested by the PTAB.

Strategic summary

Currently, all claims (1-9) of US Patent 7,020,281 remain untested by the Patent Trial and Appeal Board. The absence of PTAB activity suggests that either the patent has not been challenged through these mechanisms, or any challenges filed were not instituted or have been sealed. Given the patent expired on February 4, 2021, any new AIA trial proceedings are unlikely, as IPRs and PGRs typically target active patents to resolve validity disputes.

For a defendant currently facing assertion of this patent, the estoppel landscape under 35 U.S.C. § 315(e)(2) is not applicable, as no PTAB trials have occurred. This means that all prior art grounds remain available for challenge in district court litigation. The lack of PTAB activity indicates that the claims have not been "hardened" by surviving IPRs, nor have they been invalidated through such proceedings. The current assignee, Malikie Innovations Limited, appears to be asserting this expired patent in district court litigation, as noted in the litigation summary.

Recommended next steps

Given the absence of PTAB activity for US Patent 7,020,281, a defendant facing assertion of this patent should consider the following:

• Validity Challenge in District Court: Since no PTAB proceedings have tested the patent's claims, all prior art grounds (under 35 U.S.C. §§ 102 and 103) remain available for a defendant to assert in a district court invalidity defense. The prior art discussed in the "Prior Art" and "Obviousness" sections (e.g., Kocher's 1996 paper, US 5,991,415, US 6,175,850, and US 6,366,673) provides strong potential grounds for invalidity arguments against claims 1 and 6.
• Patent Expiration: Emphasize that the patent expired on February 4, 2021. This limits potential damages to activity occurring before this date and precludes injunctions for future activity.
• Analysis of Surviving Claims: All claims (1-9) are technically "surviving" as they have not been challenged at the PTAB. A thorough independent prior art search and analysis of each claim against the identified prior art (and potentially new art) is critical to developing a robust invalidity defense in district court.